| Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7–RILP–p150Glued and late endosome positioning N Rocha, C Kuijl, R Van Der Kant, L Janssen, D Houben, H Janssen, ... Journal of Cell Biology 185 (7), 1209-1225, 2009 | 523 | 2009 |
| Activation of endosomal dynein motors by stepwise assembly of Rab7–RILP–p150Glued, ORP1L, and the receptor βlll spectrin M Johansson, N Rocha, W Zwart, I Jordens, L Janssen, C Kuijl, ... The Journal of cell biology 176 (4), 459-471, 2007 | 456 | 2007 |
| A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility M Kedde, M Van Kouwenhove, W Zwart, JAFO Vrielink, R Elkon, R Agami Nature cell biology 12 (10), 1014-1020, 2010 | 388 | 2010 |
| Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9 G Korkmaz, R Lopes, AP Ugalde, E Nevedomskaya, R Han, K Myacheva, ... Nature biotechnology 34 (2), 192-198, 2016 | 299 | 2016 |
| Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ... Cell reports 3 (2), 342-349, 2013 | 284 | 2013 |
| Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin B Pang, X Qiao, L Janssen, A Velds, T Groothuis, R Kerkhoven, ... Nature communications 4 (1), 1-13, 2013 | 275 | 2013 |
| TRPM7 is required for breast tumor cell metastasis J Middelbeek, AJ Kuipers, L Henneman, D Visser, I Eidhof, ... Cancer research 72 (16), 4250-4261, 2012 | 176 | 2012 |
| Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis CJ Desmet, T Gallenne, A Prieur, F Reyal, NL Visser, BS Wittner, MA Smit, ... Proceedings of the National Academy of Sciences 110 (13), 5139-5144, 2013 | 148 | 2013 |
| Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape W Zwart, A Griekspoor, C Kuijl, M Marsman, J van Rheenen, H Janssen, ... Immunity 22 (2), 221-233, 2005 | 142 | 2005 |
| Phosphatidylinositol 4-kinaseβ is critical for functional association of rab11 with the Golgi complex P de Graaf, WT Zwart, RAJ van Dijken, M Deneka, TKF Schulz, N Geijsen, ... Molecular biology of the cell 15 (4), 2038-2047, 2004 | 139 | 2004 |
| PKA‐induced resistance to tamoxifen is associated with an altered orientation of ERα towards co‐activator SRC‐1 W Zwart, A Griekspoor, V Berno, K Lakeman, K Jalink, M Mancini, ... The EMBO journal 26 (15), 3534-3544, 2007 | 127 | 2007 |
| Oestrogen receptor–co‐factor–chromatin specificity in the transcriptional regulation of breast cancer W Zwart, V Theodorou, M Kok, S Canisius, S Linn, JS Carroll The EMBO journal 30 (23), 4764-4776, 2011 | 116 | 2011 |
| A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response O Krijgsman, P Roepman, W Zwart, JS Carroll, S Tian, FA de Snoo, ... Breast cancer research and treatment 133 (1), 37-47, 2012 | 108 | 2012 |
| Visualizing the action of steroid hormone receptors in living cells A Griekspoor, W Zwart, J Neefjes, R Michalides Nuclear receptor signaling 5 (1), nrs. 05003, 2007 | 105 | 2007 |
| The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen W Zwart, R de Leeuw, M Rondaij, J Neefjes, MA Mancini, R Michalides Journal of cell science 123 (8), 1253-1261, 2010 | 95 | 2010 |
| Interaction of 14-3-3 proteins with the estrogen receptor alpha F domain provides a drug target interface IJ De Vries-van Leeuwen, D da Costa Pereira, KD Flach, SR Piersma, ... Proceedings of the National Academy of Sciences 110 (22), 8894-8899, 2013 | 93 | 2013 |
| Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis MD Wellenstein, SB Coffelt, DEM Duits, MH van Miltenburg, M Slagter, ... Nature 572 (7770), 538-542, 2019 | 81 | 2019 |
| Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy? K Beelen, W Zwart, SC Linn Nature reviews Clinical oncology 9 (9), 529-541, 2012 | 80 | 2012 |
| Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancer MPHM Jansen, T Knijnenburg, EA Reijm, I Simon, R Kerkhoven, M Droog, ... Cancer research 73 (22), 6632-6641, 2013 | 78 | 2013 |
| Tamoxifen resistance: from bench to bedside M Droog, K Beelen, S Linn, W Zwart European journal of pharmacology 717 (1-3), 47-57, 2013 | 78 | 2013 |
